SAN || Psoriasis

Late-onset psoriasis genetics identified

Posted on: 28/04/2015 - 20:35

Certain genetic loci are likely associated with late-onset psoriasis, based on data from a study of 543 cases and 4,373 healthy controls. Previous stu... More »

Field of Interest: Dermatology

Type: News Item

Apremilast meets psoriasis endpoints at week 32

Posted on: 12/04/2015 - 21:04

SAN FRANCISCO – Apremilast met its primary endpoint at week 32 with no new or serious safety signals among patients with moderate to severe plaque p... More »

Field of Interest: Dermatology

Type: News Item

Ixekizumab met psoriasis endpoints by week 12, with durable response at 60 weeks

Posted on: 09/04/2015 - 15:18

SAN FRANCISCO – More than 80% of psoriasis patients who received ixekizumab achieved a 75% reduction in the Psoriasis Area and Severity Index score ... More »

Field of Interest: Dermatology

Type: News Item

Methotrexate and biologics linked to higher zoster risk in psoriasis

Posted on: 22/03/2015 - 22:50

The combination of methotrexate and biologics for the treatment of psoriasis may increase the risk of herpes zoster infection, according to a large, d... More »

Field of Interest: Dermatology

Type: News Item

New psoriasis drugs offer treatment advantages

Posted on: 27/02/2015 - 19:20

MIAMI BEACH – Two of the newest treatments available for psoriasis – apremilast and secukinumab – are true “game-changers,” according to Dr.... More »

Field of Interest: Dermatology

Type: News Item

Data suggest link between tonsillectomy, psoriasis improvement

Posted on: 25/02/2015 - 18:14

MIAMI BEACH – If all else fails in treating psoriasis, a tonsillectomy may do the trick – at least in patients whose psoriasis is associated with ... More »

Field of Interest: Dermatology

Type: News Item

Most cost-effective psoriasis treatment: methotrexate

Posted on: 30/01/2015 - 16:52

Methotrexate is the most cost-effective systemic treatment for psoriasis in terms of the number of patients needed to treat to achieve a PASI 75, acco... More »

Field of Interest: Dermatology

Type: News Item

Survey: Psoriasis/psoriatic arthritis undertreated

Posted on: 30/01/2015 - 16:20

ORLANDO – Patients with psoriasis and psoriatic arthritis have a high level of dissatisfaction with current treatment options and have numerous unme... More »

Field of Interest: Rheumatology

Type: News Item

Survey: Psoriasis/psoriatic arthritis undertreated

Posted on: 30/01/2015 - 16:20

ORLANDO – Patients with psoriasis and psoriatic arthritis have a high level of dissatisfaction with current treatment options and have numerous unme... More »

Field of Interest: Dermatology

Type: News Item

Secukinumab earns FDA approval for plaque psoriasis

Posted on: 21/01/2015 - 21:38

The U.S. Food and Drug Administration has approved secukinumab for the treatment of moderate to severe plaque psoriasis in adults. The injectable interleukin-17A inhibitor is indicated for...

Field of Interest: Dermatology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters